Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer
Cancer Treatment Reviews · 2026-07 · 148 · 103176
DOI: 10.1016/j.ctrv.2026.103176 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-07. Verfasst von Wei Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shenzhen Longhua District Central Hospital, Affiliated Longhua Hospital of Shenzhen University, Shenzhen 518110, Chin…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Claudins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shenzhen Longhua District Central Hospital, Affiliated Longhua Hospital of Shenzhen University, Shenzhen 518110, China.
- Xianning Medical College, Hubei University of Science and Technology, Xianning 437100, China. Electronic address: mwx@hbust.edu.cn.
- Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, the Affiliated Longhua Hospital of Shenzhen University, Shenzhen 518110, China. Electronic address: zengchch@glmc.edu.cn.
Zitieren
APA
Zhou, W., Mei, W., & Zeng, C. (2026). Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer. Cancer Treatment Reviews, 148, 103176. https://doi.org/10.1016/j.ctrv.2026.103176
Vancouver
Zhou W, Mei W, Zeng C. Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer. Cancer Treatment Reviews. 2026;148:103176. doi:10.1016/j.ctrv.2026.103176
BibTeX
@article{Zhou2026,
author = {Zhou, Wei and Mei, Wuxuan and Zeng, Changchun},
title = {Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {148},
pages = {103176},
doi = {10.1016/j.ctrv.2026.103176}
}
EUVIMED